(Q71645365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Dose intensification in the treatment of patients with testicular germ cell tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

S. M. O'Reilly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521654

15 May 2024

D. B. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521654

15 May 2024

E. S. Newlands

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521654

15 May 2024

G. J. Rustin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7521654

15 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7521654

15 May 2024

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

https://api.elsevier.com/content/article/PII:0959804994905614?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90561-4

https://api.elsevier.com/content/article/PII:0959804994905614?httpAccept=text/plain

15 May 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90561-4

European Journal of Cancer

15 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

30A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.

20 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90561-4

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

15 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(94)90561-4

15 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7521654%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference